Larissa Fabritz1,2, Harry J G M Crijns3, Eduard Guasch4, Andreas Goette5,6, Karl Georg Häusler7, Dipak Kotecha1, Thorsten Lewalter6,8, Christian Meyer9, Tatjana S Potpara10, Michiel Rienstra11, Renate B Schnabel6,9, Stephan Willems6,12, Guenter Breithardt6,12,13, A John Camm14, Anthony Chan15, Winnie Chua1, Mirko de Melis16, Christina Dimopoulou17, Dobromir Dobrev18, Christina Easter1, Lars Eckardt6,13, Doreen Haase6, Stephane Hatem19, Jeff S Healey20, Jordi Heijman2, Stefan H Hohnloser21, Thomas Huebner22, Bushra Saeed Ilyas15, Aaron Isaacs3, Ingo Kutschka6,23, Christophe Leclercq24, Gregory Y H Lip25, Elena Andreassi Marinelli26, Jose L Merino27, Lluís Mont28, Michael Nabauer6,29, Jonas Oldgren30, Helmut Pürerfellner31, Ursula Ravens6,32, Irina Savelieva33, Moritz F Sinner29, Alice Sitch1, Rüdiger Smolnik26, Jan Steffel34, Kenneth Stein35, Monika Stoll3, Emma Svennberg36, Dierk Thomas6,37, Isabelle C Van Gelder38, Burcu Vardar39, Reza Wakili6,18, Mattias Wieloch40, Stef Zeemering38, Paul D Ziegler16, Hein Heidbuchel41, Gerhard Hindricks42, Ulrich Schotten3,6,38, Paulus Kirchhof1,6,9. 1. Institute of Cardiovascular Sciences, University of Birmingham, UK. 2. Department of Cardiology, University Hospital Birmingham, UK. 3. School for Cardiovascular Diseases, Maastricht University Medical Centre, the Netherlands. 4. Hospital Clinic, IDIBAPS, CIBERCV, University of Barcelona, Spain. 5. Medical Clinic II, St. Vincenz Krankenhaus, Paderborn, Germany. 6. Atrial Fibrillation NETwork (AFNET), Münster, Germany. 7. Department of Neurology, University Hospital Würzburg, Germany. 8. Internistisches Klinikum München Süd, Germany. 9. University Heart Center, University Hospital Hamburg-Eppendorf, Germany. 10. School of Medicine, University of Belgrade, Clinical Centre of Serbia, Serbia. 11. University Medical Center Groningen, the Netherlands. 12. Department of Cardiology, Asklepios Klinik St. Georg, Hamburg, Germany. 13. Department of Cardiovascular Medicine, University Hospital Münster, Germany. 14. St George's Hospital Medical School, University of London, UK. 15. Pfizer. 16. Medtronic. 17. European Society of Cardiology. 18. Department of Cardiology, University Hospital Essen, Germany. 19. Department of Cardiology, Sorbonne Universités, Faculté de médecine UPMC, Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Paris, France. 20. Population Health Research Institute Hamilton, Canada. 21. Department of Cardiology, Goethe-University of Frankfurt, Germany. 22. Preventicus, Germany. 23. Klinik für Thorax-, Herz- und Gefäßchirurgie, University Hospital Göttingen, Germany. 24. Univ Rennes, CHU Rennes, INSERM, LTSI-UMR 1099, F-35000 Rennes, France. 25. Liverpool Centre for Cardiovascular Science, University of Liverpool, UK. 26. Daiichi Sankyo Europe. 27. Arrhythmia & Robotic EP Unit, La Paz University Hospital, Spain. 28. Hospital Clinic, Universitat de Barcelona, Barcelona, Catalonia, Spain. 29. Medizinische Klinik und Poliklinik I, University Hospital Munich, Germany. 30. Department of Medical Sciences, Uppsala Clinical Research Center, Uppsala University, Sweden. 31. Department für Rhythmologie und Elektrophysiologie, Ordensklinikum Linz, Austria. 32. Institut für Experimentelle Kardiovaskuläre Medizin, Universitätsherzzentrum Freiburg, Bad Krozingen, Germany. 33. St. George's University of London, UK. 34. University Heart Center Zurich, Switzerland. 35. Boston Scientific, USA. 36. Division of Cardiovascular Medicine, Department of Clinical Sciences, Karolinska Institutet, Danderyd's Hospital Stockholm, Sweden. 37. Department of Internal Medicine III-Cardiology, Angiology and Pneumonology, Medical University Hospital Heidelberg, Germany. 38. Department of Cardiology, University Medical Center Groningen, University of Groningen, the Netherlands. 39. Bayer Healthcare, Belgium. 40. Sanofi, Paris, France. 41. Department of Cardiology, Antwerp University, University Hospital, Belgium. 42. Department of Electrophysiology, Heart Center Leipzig, University of Leipzig, Germany.
Abstract
AIMS: The risk of developing atrial fibrillation (AF) and its complications continues to increase, despite good progress in preventing AF-related strokes. METHODS AND RESULTS: This article summarizes the outcomes of the 7th Consensus Conference of the Atrial Fibrillation NETwork (AFNET) and the European Heart Rhythm Association (EHRA) held in Lisbon in March 2019. Sixty-five international AF specialists met to present new data and find consensus on pressing issues in AF prevention, management and future research to improve care for patients with AF and prevent AF-related complications. This article is the main outcome of an interactive, iterative discussion between breakout specialist groups and the meeting plenary. AF patients have dynamic risk profiles requiring repeated assessment and risk-based therapy stratification to optimize quality of care. Interrogation of deeply phenotyped datasets with outcomes will lead to a better understanding of the cardiac and systemic effects of AF, interacting with comorbidities and predisposing factors, enabling stratified therapy. New proposals include an algorithm for the acute management of patients with AF and heart failure, a call for a refined, data-driven assessment of stroke risk, suggestions for anticoagulation use in special populations, and a call for rhythm control therapy selection based on risk of AF recurrence. CONCLUSION: The remaining morbidity and mortality in patients with AF needs better characterization. Likely drivers of the remaining AF-related problems are AF burden, potentially treatable by rhythm control therapy, and concomitant conditions, potentially treatable by treating these conditions. Identifying the drivers of AF-related complications holds promise for stratified therapy. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: The risk of developing atrial fibrillation (AF) and its complications continues to increase, despite good progress in preventing AF-related strokes. METHODS AND RESULTS: This article summarizes the outcomes of the 7th Consensus Conference of the Atrial Fibrillation NETwork (AFNET) and the European Heart Rhythm Association (EHRA) held in Lisbon in March 2019. Sixty-five international AF specialists met to present new data and find consensus on pressing issues in AF prevention, management and future research to improve care for patients with AF and prevent AF-related complications. This article is the main outcome of an interactive, iterative discussion between breakout specialist groups and the meeting plenary. AFpatients have dynamic risk profiles requiring repeated assessment and risk-based therapy stratification to optimize quality of care. Interrogation of deeply phenotyped datasets with outcomes will lead to a better understanding of the cardiac and systemic effects of AF, interacting with comorbidities and predisposing factors, enabling stratified therapy. New proposals include an algorithm for the acute management of patients with AF and heart failure, a call for a refined, data-driven assessment of stroke risk, suggestions for anticoagulation use in special populations, and a call for rhythm control therapy selection based on risk of AF recurrence. CONCLUSION: The remaining morbidity and mortality in patients with AF needs better characterization. Likely drivers of the remaining AF-related problems are AF burden, potentially treatable by rhythm control therapy, and concomitant conditions, potentially treatable by treating these conditions. Identifying the drivers of AF-related complications holds promise for stratified therapy. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Julius Obergassel; Molly O'Reilly; Laura C Sommerfeld; S Nashitha Kabir; Christopher O'Shea; Fahima Syeda; Lars Eckardt; Paulus Kirchhof; Larissa Fabritz Journal: Europace Date: 2021-06-07 Impact factor: 5.214
Authors: Shinwan Kany; Bruno Reissmann; Andreas Metzner; Paulus Kirchhof; Dawood Darbar; Renate B Schnabel Journal: Cardiovasc Res Date: 2021-06-16 Impact factor: 10.787
Authors: Astrid N L Hermans; Monika Gawałko; Henrike A K Hillmann; Afzal Sohaib; Rachel M J van der Velden; Konstanze Betz; Dominique Verhaert; Daniel Scherr; Julia Meier; Arian Sultan; Daniel Steven; Elena Terentieva; Ron Pisters; Martin Hemels; Leonard Voorhout; Piotr Lodziński; Bartosz Krzowski; Dhiraj Gupta; Nikola Kozhuharov; Henri Gruwez; Kevin Vernooy; Nikki A H A Pluymaekers; Jeroen M Hendriks; Martin Manninger; David Duncker; Dominik Linz Journal: Front Cardiovasc Med Date: 2022-01-19
Authors: Marco Proietti; Marina Camera; Maurizio Gallieni; Luigi Gianturco; Antonio Gidaro; Carlo Piemontese; Giuseppe Pizzetti; Franco Redaelli; Barbara Scimeca; Carlo Sebastiano Tadeo; Matteo Cesari; Giuseppe Bellelli; Laura Adelaide Dalla Vecchia Journal: J Pers Med Date: 2022-03-15
Authors: Andreas Rillig; Christina Magnussen; Ann-Kathrin Ozga; Anna Suling; Axel Brandes; Günter Breithardt; A John Camm; Harry J G M Crijns; Lars Eckardt; Arif Elvan; Andreas Goette; Michele Gulizia; Laurent Haegeli; Hein Heidbuchel; Karl-Heinz Kuck; Andre Ng; Lukasz Szumowski; Isabelle van Gelder; Karl Wegscheider; Paulus Kirchhof Journal: Circulation Date: 2021-07-30 Impact factor: 29.690
Authors: Michael Kühne; Christine S Zuern; Peter Hämmerle; Stefanie Aeschbacher; Anne Springer; Ceylan Eken; Michael Coslovsky; Gilles Dutilh; Giorgio Moschovitis; Nicolas Rodondi; Patricia Chocano; David Conen; Stefan Osswald Journal: Clin Res Cardiol Date: 2021-06-22 Impact factor: 5.460